infliximab (Remicade)
EU-073
Phase 2 small_molecule completed
Quick answer
infliximab (Remicade) for COPD is a Phase 2 program (small_molecule) at INTEGRATED BIOPHARMA INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INTEGRATED BIOPHARMA INC
- Indication
- COPD
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed